118 related articles for article (PubMed ID: 20887218)
1. International symposium on natural immunity to HIV: a gathering of the HIV‐exposed seronegative clan.
Meyers AF; Fowke KR
J Infect Dis; 2010 Nov; 202 Suppl 3():S327-8. PubMed ID: 20887218
[TBL] [Abstract][Full Text] [Related]
2. Proceedings of the International Symposium on Natural Immunity to HIV. Winnipeg, Manitoba, Canada. November 2009.
J Infect Dis; 2010 Nov; 202 Suppl 3():S327-86. PubMed ID: 21038473
[No Abstract] [Full Text] [Related]
3. Cohorts for the study of HIV‐1-exposed but uninfected individuals: benefits and limitations.
Horton RE; McLaren PJ; Fowke K; Kimani J; Ball TB
J Infect Dis; 2010 Nov; 202 Suppl 3():S377-81. PubMed ID: 20887228
[TBL] [Abstract][Full Text] [Related]
4. Mucosal innate immunity as a determinant of HIV susceptibility.
Iqbal SM; Kaul R
Am J Reprod Immunol; 2008 Jan; 59(1):44-54. PubMed ID: 18154595
[TBL] [Abstract][Full Text] [Related]
5. Innate molecular and anatomic mucosal barriers against HIV infection in the genital tract of HIV‐exposed seronegative individuals.
Broliden K
J Infect Dis; 2010 Nov; 202 Suppl 3():S351-5. PubMed ID: 20887223
[TBL] [Abstract][Full Text] [Related]
6. [Soluble factors with inhibitory activity against type 1 Human Immunodeficiency Virus].
Zapata W; Montoya CJ; Rugeles MT
Biomedica; 2006 Sep; 26(3):451-66. PubMed ID: 17176009
[TBL] [Abstract][Full Text] [Related]
7. Mind the gap: lack of association between KIR3DL1*004/HLA‐Bw4-induced natural killer cell function and protection from HIV infection.
Parsons MS; Boulet S; Song R; Bruneau J; Shoukry NH; Routy JP; Tsoukas CM; Bernard NF
J Infect Dis; 2010 Nov; 202 Suppl 3():S356-60. PubMed ID: 20887224
[TBL] [Abstract][Full Text] [Related]
8. Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals.
Kulkarni PS; Butera ST; Duerr AC
AIDS Rev; 2003; 5(2):87-103. PubMed ID: 12876898
[TBL] [Abstract][Full Text] [Related]
9. Natural resistance to HIV infection: lessons learned from HIV‐exposed uninfected individuals.
Pancino G; Saez-Cirion A; Scott-Algara D; Paul P
J Infect Dis; 2010 Nov; 202 Suppl 3():S345-50. PubMed ID: 20887222
[TBL] [Abstract][Full Text] [Related]
10. Can immune responses to human immunodeficiency virus be preserved, enhanced, or restored?
Walker BD
AIDS Clin Rev; 2000-2001; ():101-14. PubMed ID: 10999218
[No Abstract] [Full Text] [Related]
11. Natural immunity to HIV and its possible relationship to vaccine strategies.
Bolognesi DP
Microbiol Sci; 1988 Aug; 5(8):236-41. PubMed ID: 2484203
[TBL] [Abstract][Full Text] [Related]
12. Role of cytokines and chemokines in the regulation of innate immunity and HIV infection.
Alfano M; Poli G
Mol Immunol; 2005 Feb; 42(2):161-82. PubMed ID: 15488606
[TBL] [Abstract][Full Text] [Related]
13. Natural resistance to HIV?
Hill CM; Littman DR
Nature; 1996 Aug; 382(6593):668-9. PubMed ID: 8751431
[No Abstract] [Full Text] [Related]
14. Notes on the pathogenesis of human immunodeficiency virus infection.
Piconi S; Clerici M
Ann Ist Super Sanita; 1997; 33(2):219-23. PubMed ID: 9470244
[TBL] [Abstract][Full Text] [Related]
15. Acute HIV-1 infection: what's new? Where are we going?
D'Souza MP; Axten KL; Hecht FM; Altfeld M
J Infect Dis; 2010 Oct; 202 Suppl 2():S267-9. PubMed ID: 20846032
[TBL] [Abstract][Full Text] [Related]
16. Cytokines and HIV/AIDS: a critical look at the existing relationship between them.
Ekene OC
Roum Arch Microbiol Immunol; 2008; 67(3-4):67-80. PubMed ID: 19496474
[TBL] [Abstract][Full Text] [Related]
17. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
18. Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection.
Clerici M; Tacket CO; Via CS; Lucey DR; Muluk SC; Zajac RA; Boswell RN; Berzofsky JA; Shearer GM
Eur J Immunol; 1991 Jun; 21(6):1345-9. PubMed ID: 1845391
[TBL] [Abstract][Full Text] [Related]
19. Modulation of innate and adaptive immunity by lactoferrin in human immunodeficiency virus (HIV)-infected, antiretroviral therapy-naïve children.
Zuccotti GV; Vigano A; Borelli M; Saresella M; Giacomet V; Clerici M
Int J Antimicrob Agents; 2007 Mar; 29(3):353-5. PubMed ID: 17276659
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons.
Bernard NF; Yannakis CM; Lee JS; Tsoukas CM
J Infect Dis; 1999 Mar; 179(3):538-47. PubMed ID: 9952359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
